23.05.2013 - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a new type of treatment for patients with depression that have failed to benefit from standard...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)